Chemoprevention by aerosolized bexarotene in mouse models of all three major subtypes of lung cancer: adenocarcinoma, squamous cell carcinoma and small cell lung cancer.
Ended Awarded Last action
- Contract number
- HHSN26100007
- Awardee
-
University Of Oklahoma UEI GY8NMUZQXVS7 Part of University Of Oklahoma
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $607,113
Award facts
- Contract value 100% obligated
- $607,113.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Oklahoma City, OK 73104, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Modification | $607,113 | |
| Other Administrative Action | $0 |
About this award
This is a firm-fixed price delivery order awarded by the National Cancer Institute, a civilian agency, to the University of Oklahoma Univ Of Oklahoma Health Sciences Center Division. The award, valued at $607,113.00, is for a pre-clinical study to investigate the use of aerosolized bexarotene as a chemopreventive agent against the three major subtypes of lung cancer in mouse models. This work is being performed under the Preclinical Agent Development Assays 2012-2016 indefinite delivery contract. The University of Oklahoma has subcontracted with the Medical College of Wisconsin, Inc. to conduct the animal study. No set-aside designation was used for this award.
Quick answers
Who was awarded contract HHSN26100007?
HHSN26100007 was awarded to University Of Oklahoma by National Cancer Institute (National Institutes of Health) on September 12, 2014.
How much is contract HHSN26100007 worth?
The government has obligated $607,113 on HHSN26100007.
Is contract HHSN26100007 an order under another contract?
Yes. HHSN26100007 is a delivery order under HHSN261201200020I, an indefinite delivery contract, on Preclinical Agent Development Assays 2012-2016.
Was contract HHSN26100007 competed?
The extent of competition for HHSN26100007 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award